ArticleMethods in molecular biology (Clifton, N.J.)2026
Direct Reprogramming of Microglia into Neurons.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recent years, direct reprogramming methods have attracted attention as they can bypass the immature stem cell state and directly induce the desired cell type by introducing key transcription factors into somatic cells. This technique offers advantages such as shorter induction times compared to inducing the desired cells from induced pluripotent stem cells. Furthermore, this approach enables the provision of the requisite cell types to patients requiring treatment without eliciting an immune rejection response. Microglia, the resident immune cells of the central nervous system, exhibit high proliferative and regenerative capacities, allowing them to repopulate even after almost complete depletion. In response to injury, microglia accumulate in damaged brain regions and become the primary cell type that forms the glial scar. Given these properties, microglia are promising candidates for direct reprogramming into neurons in the injured area without depleting cell sources. This chapter outlines a protocol for directly reprogramming cortical microglia into neurons, utilizing primary culture and lentiviral-mediated gene transfer techniques.
Indexed as
Identifiers
41273648What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.